중앙백신
072020KOSDAQ기초 의약물질 제조업66.8 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
Central Vaccine is a company specializing in the development and production of animal vaccines and biological products, focusing on disease prevention and control in the livestock industry. Recent outbreaks of African Swine Fever and Highly Pathogenic Avian Influenza have increased demand for vaccines, necessitating the development of new products to counteract the diminishing efficacy of existing ones. The company is expanding into new markets, including China and Brazil, to broaden its global presence.
Number of Employees
194people
Average Salary
57.1M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Half of industry avg (excellent)
Well below industry avg
In line with industry avg
Avg ▲8.3% (2-year basis)
Avg ▼2.6% (2-year basis)
Avg ROE 6.3% (declining, 3yr)
Detailed News Sentiment
- Neutral중앙백신, 윤인중·윤석인 각자 대표이사 체제 변경
중앙백신이 윤석인 대표이사 신규 선임으로 윤인중·윤석인 각자 대표이사 체제로 변경되었다.
Detailed Momentum
52w mid range (41%)
1m +2.29% (slight rise)
Volume decreasing
Detailed Disclosure
- Neutral기업가치제고계획(자율공시) (2026년 주식회사 중앙백신연구소 기업가치 제고 계획)2026-03-25
- Neutral정기주주총회결과2026-03-24
- Neutral대표이사변경2026-03-24
- Neutral사업보고서 (2025.12)2026-03-16
- Neutral감사보고서제출2026-03-16
